These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
622 related articles for article (PubMed ID: 8682282)
21. Integration of estrogen and progesterone receptors with pathological and molecular prognostic factors in breast cancer patients. Gago FE; Tello OM; Diblasi AM; Ciocca DR J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):431-7. PubMed ID: 10030692 [TBL] [Abstract][Full Text] [Related]
22. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer. Horita K; Yamaguchi A; Hirose K; Ishida M; Noriki S; Imamura Y; Fukuda M Eur J Histochem; 2001; 45(1):73-84. PubMed ID: 11411868 [TBL] [Abstract][Full Text] [Related]
23. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer. Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508 [TBL] [Abstract][Full Text] [Related]
24. Nonlinear discriminant analysis and prognostic factor classification in node-negative primary breast cancer using probabilistic neural networks. Le Goff JM; Lavayssière L; Rouëssé J; Spyratos F Anticancer Res; 2000; 20(3B):2213-8. PubMed ID: 10928180 [TBL] [Abstract][Full Text] [Related]
25. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse. Harbeck N; Thomssen C; Berger U; Ulm K; Kates RE; Höfler H; Jänicke F; Graeff H; Schmitt M Breast Cancer Res Treat; 1999 Mar; 54(2):147-57. PubMed ID: 10424405 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
27. Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors. Marsigliante S; Biscozzo L; Correale M; Paradiso A; Leo G; Abbate I; Dragone CD; Storelli C Br J Cancer; 1994 Mar; 69(3):550-4. PubMed ID: 8123486 [TBL] [Abstract][Full Text] [Related]
28. Biochemical parameters for prognostic evaluation in patients with breast cancer. Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Sampognaro E; Meo S Anticancer Res; 1994; 14(2B):693-8. PubMed ID: 8010728 [TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance]. Beckmann MW; Tutschek B; Göhring UJ; Engels K; Picard FK; Scharl A; Niederacher D; Schnürch HG Geburtshilfe Frauenheilkd; 1995 May; 55(5):258-65. PubMed ID: 7607382 [TBL] [Abstract][Full Text] [Related]
31. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. Isola J; Weitz S; Visakorpi T; Holli K; Shea R; Khabbaz N; Kallioniemi OP J Clin Oncol; 1993 Jan; 11(1):36-43. PubMed ID: 8093367 [TBL] [Abstract][Full Text] [Related]
32. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis. Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M Oncology; 2001; 60(1):72-80. PubMed ID: 11150912 [TBL] [Abstract][Full Text] [Related]
33. p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer. Clahsen PC; van de Velde CJ; Duval C; Pallud C; Mandard AM; Delobelle-Deroide A; van den Broek L; Sahmoud TM; van de Vijver MJ J Clin Oncol; 1998 Feb; 16(2):470-9. PubMed ID: 9469330 [TBL] [Abstract][Full Text] [Related]
34. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination. Yu H; Levesque MA; Clark GM; Diamandis EP Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775 [TBL] [Abstract][Full Text] [Related]
35. Prognostic impact of tumor biological factors on survival in node-negative breast cancer. Harbeck N; Dettmar P; Thomssen C; Henselmann B; Kuhn W; Ulm K; Jänicke F; Höfler H; Graeff H; Schmitt M Anticancer Res; 1998; 18(3C):2187-97. PubMed ID: 9703782 [TBL] [Abstract][Full Text] [Related]
36. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. Gasparini G; Weidner N; Bevilacqua P; Maluta S; Dalla Palma P; Caffo O; Barbareschi M; Boracchi P; Marubini E; Pozza F J Clin Oncol; 1994 Mar; 12(3):454-66. PubMed ID: 7509851 [TBL] [Abstract][Full Text] [Related]
37. [Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation]. Ruibal A; Arias JI; Resino C; Lapeña G; Schneider J; Tejerina A Rev Esp Med Nucl; 2001 Aug; 20(5):365-8. PubMed ID: 11470070 [TBL] [Abstract][Full Text] [Related]
38. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years. Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650 [TBL] [Abstract][Full Text] [Related]
39. Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases. Têtu B; Brisson J; Lapointe H; Wang CS; Bernard P; Blanchette C Breast Cancer Res Treat; 1999 May; 55(2):137-47. PubMed ID: 10481941 [TBL] [Abstract][Full Text] [Related]
40. Age-associated biomarker profiles of human breast cancer. Eppenberger-Castori S; Moore DH; Thor AD; Edgerton SM; Kueng W; Eppenberger U; Benz CC Int J Biochem Cell Biol; 2002 Nov; 34(11):1318-30. PubMed ID: 12200028 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]